Nurain Mohd Noor

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Switching from sulphonylurea to a sodium‐glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia

Wan Juani Wan Seman, Najma Kori, Subashini Rajoo et al. · Diabetes Obesity and Metabolism · 2016 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +13

The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes

Mohamed Hassanein, Zanariah Hussein, Inass Shaltout et al. · Diabetes Research and Clinical Practice · 2021 · 57 citations · Full text

Medicine, Geriatric Medicine, Nutrition +15

What information and the extent of information research participants need in informed consent forms: a multi-country survey

Juntra Karbwang, Nut Koonrungsesomboon, Cristina Torres et al. · BMC Medical Ethics · 2018 · 41 citations · Full text

Public Health, Health Sciences, Health Services Research +8